ObsEva SA (OBSV)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

CHEMIN DES AULX, 12 PLAN-LES-OUATES, SWITZERLAND 1228

ObsEva SA operates as a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. ObsEva serves customers worldwide.

Data as of 2020-05-30
Market Cap166.774 Million Shares Outstanding44.592 Million Avg 30-day Volume786.782 Thousand
P/E Ratio Dividend Yield EPS-2.39
Price/Sales Price cash flow ratio Price free cash flow ratio-2.1
Book Value0.81 Price to Tangible Book16.06 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low12.97 / 1.63 Stddev
View SEC Filings from OBSV instead.

Funds Holding OBSV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OBSV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments